Literature DB >> 20825490

Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves.

D K Pal1, W Li, T Clarke, P Lieberman, L J Strug.   

Abstract

We recently showed genomewide linkage of centrotemporal sharp waves (CTS) in classic Rolandic epilepsy (RE) families to chromosome 11p13, and fine-mapped this locus to variants in the ELP4 gene. Speech sound disorder (SSD) is a common comorbidity in RE subjects, of unknown etiology, which co-aggregates in family members in a manner that could hypothetically be explained by shared underlying genetic risk with CTS. Furthermore, the neural mechanism of SSD is unknown, although individuals with rare, Mendelian forms of RE are described with severe verbal and oromotor apraxia. We therefore first performed genomewide linkage analysis for SSD, operationally defined as clinical history consistent with ICD-10 speech articulation disorder, in 38 families singly ascertained through a proband with RE. We tested the hypothesis of shared genetic risk with CTS at the 11p13 locus. In the second part of the study we used computerized acoustic analysis of recorded speech to test the hypothesis of dyspraxia as a mechanism for SSD in a smaller subset of RE probands and relatives. In two-point and multipoint LOD score analysis, we found that evidence for linkage to the 11p13 locus increased substantially when the phenotype was broadened from CTS to CTS/SSD. In multipoint analysis, the LOD score rose by 3.2 to HLOD 7.54 at D11S914 for CTS/SSD, the same marker at which multipoint linkage maximized for CTS alone. Non-parametric, affected-only methods in a sub-set of the data provide further confirmatory evidence for pleiotropy. In acoustic analysis there were voice-onset time abnormalities in 10/18 RE probands, 8/16 siblings and 5/15 parents, providing evidence of breakdown in the spatial/temporal properties of speech articulation consistent with a dyspraxic mechanism. The results from genetic and physiological studies suggest a pleiotropic role for the 11p13 locus in the development of both SSD and CTS, and also indicate a dyspraxic mechanism for the SSD linked to 11p13. Taken together, these data strongly support a neurodevelopmental origin for classic RE.
© 2010 The Authors. Genes, Brain and Behavior © 2010 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Year:  2010        PMID: 20825490     DOI: 10.1111/j.1601-183X.2010.00648.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  18 in total

1.  A neurodevelopmental basis for BECTS: evidence from structural MRI.

Authors:  Heath R Pardoe; Anne T Berg; John S Archer; Robert K Fulbright; Graeme D Jackson
Journal:  Epilepsy Res       Date:  2013-01-31       Impact factor: 3.045

Review 2.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

3.  A neurocognitive endophenotype associated with rolandic epilepsy.

Authors:  Anna B Smith; Peregrine M Kavros; Tara Clarke; Nelson J Dorta; Geoffrey Tremont; Deb K Pal
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

4.  Encoding, memory, and transcoding deficits in Childhood Apraxia of Speech.

Authors:  Lawrence D Shriberg; Heather L Lohmeier; Edythe A Strand; Kathy J Jakielski
Journal:  Clin Linguist Phon       Date:  2012-05       Impact factor: 1.346

5.  Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome.

Authors:  Gordana Raca; Becky S Baas; Salman Kirmani; Jennifer J Laffin; Craig A Jackson; Edythe A Strand; Kathy J Jakielski; Lawrence D Shriberg
Journal:  Eur J Hum Genet       Date:  2012-08-22       Impact factor: 4.246

6.  Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.

Authors:  Johannes R Lemke; Dennis Lal; Eva M Reinthaler; Isabelle Steiner; Michael Nothnagel; Michael Alber; Kirsten Geider; Bodo Laube; Michael Schwake; Katrin Finsterwalder; Andre Franke; Markus Schilhabel; Johanna A Jähn; Hiltrud Muhle; Rainer Boor; Wim Van Paesschen; Roberto Caraballo; Natalio Fejerman; Sarah Weckhuysen; Peter De Jonghe; Jan Larsen; Rikke S Møller; Helle Hjalgrim; Laura Addis; Shan Tang; Elaine Hughes; Deb K Pal; Kadi Veri; Ulvi Vaher; Tiina Talvik; Petia Dimova; Rosa Guerrero López; José M Serratosa; Tarja Linnankivi; Anna-Elina Lehesjoki; Susanne Ruf; Markus Wolff; Sarah Buerki; Gabriele Wohlrab; Judith Kroell; Alexandre N Datta; Barbara Fiedler; Gerhard Kurlemann; Gerhard Kluger; Andreas Hahn; D Edda Haberlandt; Christina Kutzer; Jürgen Sperner; Felicitas Becker; Yvonne G Weber; Martha Feucht; Hannelore Steinböck; Birgit Neophythou; Gabriel M Ronen; Ursula Gruber-Sedlmayr; Julia Geldner; Robert J Harvey; Per Hoffmann; Stefan Herms; Janine Altmüller; Mohammad R Toliat; Holger Thiele; Peter Nürnberg; Christian Wilhelm; Ulrich Stephani; Ingo Helbig; Holger Lerche; Fritz Zimprich; Bernd A Neubauer; Saskia Biskup; Sarah von Spiczak
Journal:  Nat Genet       Date:  2013-08-11       Impact factor: 38.330

Review 7.  Language Dysfunction in Pediatric Epilepsy.

Authors:  Fiona M Baumer; Aaron L Cardon; Brenda E Porter
Journal:  J Pediatr       Date:  2017-12-11       Impact factor: 4.406

Review 8.  Imaging and genetics of language and cognition in pediatric epilepsy.

Authors:  Laura Addis; Jack J Lin; Deb K Pal; Bruce Hermann; Rochelle Caplan
Journal:  Epilepsy Behav       Date:  2012-10-30       Impact factor: 2.937

Review 9.  How should we be searching for genes for common epilepsy? A critique and a prescription.

Authors:  David A Greenberg; William C L Stewart
Journal:  Epilepsia       Date:  2012-09       Impact factor: 5.864

10.  Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization.

Authors:  Jennifer J S Laffin; Gordana Raca; Craig A Jackson; Edythe A Strand; Kathy J Jakielski; Lawrence D Shriberg
Journal:  Genet Med       Date:  2012-07-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.